BLXA4

DB12133InvestigationalSmall molecule

BLXA4 has been used in trials studying the treatment of Gingival Inflammation.

Chemical structure of BLXA4
Formula / weight
C22H32O5 · 376.493 g/mol (avg)

Resolves to

Compound
UNIILXE89WJ787CAS864516-86-9PubChem58185197
Structure
InChIKeyHEDVTGFTYROYFE-RREUNBNVSA-NSMILESCCCCC[C@@H](O)\C=C\C1=CC=CC=C1\C=C\[C@@H](O)[C@@H](O)CCCC(O)=O

What you can answer from here — as of April 02, 2025

1Clinical trialPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of BLXA4, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In